{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T22:36:45Z","timestamp":1777934205791,"version":"3.51.4"},"reference-count":37,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2012,11,16]],"date-time":"2012-11-16T00:00:00Z","timestamp":1353024000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Oncol Pharm Pract"],"published-print":{"date-parts":[[2013,9]]},"abstract":"<jats:p>While the development of epidermal growth factor receptor inhibitors has been hailed as a remarkable triumph in the field of oncology, it has inherited with it a host of cutaneous side-effects that have been increasingly observed in a substantial number of patients in the recent years. One cutaneous manifestation that may inflict significant pain and affect activities of daily living among some of the patients receiving epidermal growth factor receptor inhibitors is paronychia. A case of paronychia associated with the use of cetuximab in the management of KRAS wild-type midrectal adenocarcinoma along with its management has been described.<\/jats:p>","DOI":"10.1177\/1078155212461289","type":"journal-article","created":{"date-parts":[[2012,11,17]],"date-time":"2012-11-17T20:44:07Z","timestamp":1353185047000},"page":"273-278","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Paronychia induced by the epidermal growth factor receptor inhibitor cetuximab"],"prefix":"10.1177","volume":"19","author":[{"given":"Soo Lin","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boon Seang","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Oncology and Radiotherapy, Hospital Pulau Pinang, Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee Chin","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Hospital Pulau Pinang, Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2012,11,16]]},"reference":[{"key":"bibr1-1078155212461289","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.11.004"},{"key":"bibr2-1078155212461289","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.09.013"},{"key":"bibr3-1078155212461289","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1970"},{"key":"bibr4-1078155212461289","first-page":"549","volume":"3","author":"Graham J","year":"2004","journal-title":"Nat Rev"},{"key":"bibr5-1078155212461289","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0805019"},{"key":"bibr6-1078155212461289","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdq222"},{"key":"bibr7-1078155212461289","unstructured":"BC Cancer Agency Protocol Summary UGIAVCETIR. BCCA Protocol Summary Third Line Treatment of Metastatic Colorectal Cancer Using Cetuximab in Combination with Irinotecan, 2009; revised 2012."},{"key":"bibr8-1078155212461289","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.02.4646"},{"key":"bibr9-1078155212461289","first-page":"786","volume":"12","author":"Busam K","year":"1999","journal-title":"Mod Patho"},{"key":"bibr10-1078155212461289","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa033025"},{"key":"bibr11-1078155212461289","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-0792"},{"key":"bibr12-1078155212461289","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.09.005"},{"key":"bibr13-1078155212461289","doi-asserted-by":"publisher","DOI":"10.1159\/000088502"},{"key":"bibr14-1078155212461289","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdi279"},{"key":"bibr15-1078155212461289","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1244831"},{"key":"bibr16-1078155212461289","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2001.04226.x"},{"key":"bibr17-1078155212461289","doi-asserted-by":"publisher","DOI":"10.1080\/00015550310005898"},{"key":"bibr18-1078155212461289","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2009.03446.x"},{"key":"bibr19-1078155212461289","first-page":"5","volume":"5","author":"Armstrong K","year":"2011","journal-title":"J Dermatol"},{"key":"bibr20-1078155212461289","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1999.02883.x"},{"key":"bibr21-1078155212461289","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.20.1.110"},{"key":"bibr22-1078155212461289","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1986.tb00439.x"},{"key":"bibr23-1078155212461289","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/cdf331"},{"key":"bibr24-1078155212461289","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.10.9.8801161"},{"key":"bibr25-1078155212461289","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2002.04864.x"},{"key":"bibr26-1078155212461289","first-page":"1","volume":"16","author":"Ehmann L","year":"2011","journal-title":"Skin Therapy Letter"},{"key":"bibr27-1078155212461289","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.124621"},{"key":"bibr28-1078155212461289","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.02.168"},{"key":"bibr29-1078155212461289","doi-asserted-by":"publisher","DOI":"10.1159\/000073100"},{"key":"bibr30-1078155212461289","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.04.169"},{"key":"bibr31-1078155212461289","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.07010.x"},{"key":"bibr32-1078155212461289","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2009.03516.x"},{"key":"bibr33-1078155212461289","doi-asserted-by":"publisher","DOI":"10.1111\/j.1747-4477.2007.00071.x"},{"key":"bibr34-1078155212461289","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2009.03490.x"},{"key":"bibr35-1078155212461289","doi-asserted-by":"publisher","DOI":"10.1177\/08959374980120010501"},{"key":"bibr36-1078155212461289","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-011-1197-6"},{"key":"bibr37-1078155212461289","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.04.062"}],"container-title":["Journal of Oncology Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1078155212461289","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1078155212461289","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1078155212461289","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T02:14:46Z","timestamp":1777688086000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1078155212461289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,16]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["10.1177\/1078155212461289"],"URL":"https:\/\/doi.org\/10.1177\/1078155212461289","relation":{},"ISSN":["1078-1552","1477-092X"],"issn-type":[{"value":"1078-1552","type":"print"},{"value":"1477-092X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,16]]}}}